Zynerba Provides Clinical Update for Lead Development Candidates – ZYN001 and ZYN002 By GlobeNewswire, October 17, 2016, 07:00:00 AM EDT Vote upAAA Phase 1 clinical trial for ZYN001 is expected to begin in 1H17 Read more: http://www.nasdaq.com/press-release/zynerba-provides-clinical-update-for-lead-development--candidates--zyn001-and-zyn002-20161017-00151#ixzz4Nio5mdND